Market Closed -
Toronto S.E.
04:00:00 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
6.54
CAD
|
+2.67%
|
|
-0.30%
|
-6.03%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
2,716
|
1,656
|
1,311
|
1,234
|
-
|
Enterprise Value (EV)
1 |
3,728
|
2,605
|
2,319
|
2,239
|
2,250
|
P/E ratio
|
-13.3
x
|
-98.9
x
|
-15.1
x
|
-67.6
x
|
-527
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.63
x
|
1.32
x
|
0.92
x
|
0.79
x
|
0.71
x
|
EV / Revenue
|
3.62
x
|
2.08
x
|
1.63
x
|
1.43
x
|
1.3
x
|
EV / EBITDA
|
19.4
x
|
11.3
x
|
8.93
x
|
7.8
x
|
7
x
|
EV / FCF
|
92
x
|
28.8
x
|
18.3
x
|
15.2
x
|
12.7
x
|
FCF Yield
|
1.09%
|
3.47%
|
5.47%
|
6.57%
|
7.89%
|
Price to Book
|
1.81
x
|
0.93
x
|
0.75
x
|
0.72
x
|
0.74
x
|
Nbr of stocks (in thousands)
|
166,911
|
186,034
|
188,413
|
188,657
|
-
|
Reference price
2 |
16.27
|
8.900
|
6.960
|
6.540
|
6.540
|
Announcement Date
|
3/25/22
|
3/23/23
|
3/22/24
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
-
|
1,031
|
1,250
|
1,426
|
1,564
|
1,727
|
EBITDA
1 |
-
|
191.8
|
230.6
|
259.7
|
287.1
|
321.6
|
EBIT
1 |
-
|
-81.5
|
40.3
|
56.6
|
135.7
|
172.8
|
Operating Margin
|
-
|
-7.91%
|
3.22%
|
3.97%
|
8.67%
|
10%
|
Earnings before Tax (EBT)
1 |
-
|
-171.2
|
-77.4
|
-102.5
|
23
|
136.9
|
Net income
1 |
-169.2
|
-160.4
|
-16.6
|
-85.6
|
-17.6
|
-9.821
|
Net margin
|
-
|
-15.56%
|
-1.33%
|
-6%
|
-1.13%
|
-0.57%
|
EPS
2 |
-1.890
|
-1.220
|
-0.0900
|
-0.4600
|
-0.0967
|
-0.0124
|
Free Cash Flow
1 |
-
|
40.5
|
90.4
|
126.9
|
147
|
177.5
|
FCF margin
|
-
|
3.93%
|
7.23%
|
8.9%
|
9.4%
|
10.27%
|
FCF Conversion (EBITDA)
|
-
|
21.12%
|
39.2%
|
48.86%
|
51.21%
|
55.18%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/30/21
|
3/25/22
|
3/23/23
|
3/22/24
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
250.2
|
272.5
|
280.2
|
327
|
312.1
|
331
|
358.3
|
368.3
|
336.9
|
362.2
|
374.5
|
403.4
|
380
|
406.4
|
416.9
|
EBITDA
1 |
46.2
|
50.1
|
50.1
|
59.8
|
59.3
|
60.6
|
65.6
|
67
|
60.9
|
65.8
|
68.24
|
73.84
|
69.87
|
75.49
|
77
|
EBIT
1 |
-6.8
|
-16.37
|
8.6
|
11.8
|
9.6
|
9.5
|
5.8
|
16.5
|
10.7
|
15.1
|
31.47
|
36.27
|
30.25
|
37.7
|
-
|
Operating Margin
|
-2.72%
|
-6.01%
|
3.07%
|
3.61%
|
3.08%
|
2.87%
|
1.62%
|
4.48%
|
3.18%
|
4.17%
|
8.4%
|
8.99%
|
7.96%
|
9.28%
|
-
|
Earnings before Tax (EBT)
|
-22.7
|
-42
|
-24.5
|
-2.8
|
-16.9
|
-33.3
|
-
|
-
|
-12.6
|
-43.1
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
-18.4
|
-43.1
|
-11
|
2.4
|
-14.7
|
6.6
|
-33.3
|
-7.3
|
-9.8
|
-35.1
|
-3.8
|
-0.4
|
-5.4
|
1
|
-
|
Net margin
|
-7.35%
|
-15.82%
|
-3.93%
|
0.73%
|
-4.71%
|
1.99%
|
-9.29%
|
-1.98%
|
-2.91%
|
-9.69%
|
-1.01%
|
-0.1%
|
-1.42%
|
0.25%
|
-
|
EPS
|
-0.1100
|
-0.2400
|
-0.0600
|
0.0100
|
-0.0800
|
0.0400
|
-0.1800
|
-0.0400
|
-0.0500
|
-0.1900
|
-
|
-0.0558
|
-0.0419
|
-0.0257
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/15/21
|
3/25/22
|
5/10/22
|
8/12/22
|
11/9/22
|
3/23/23
|
5/12/23
|
8/4/23
|
11/8/23
|
3/22/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
-
|
1,012
|
950
|
1,008
|
1,005
|
1,016
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
5.276
x
|
4.118
x
|
3.88
x
|
3.502
x
|
3.159
x
|
Free Cash Flow
1 |
-
|
40.5
|
90.4
|
127
|
147
|
177
|
ROE (net income / shareholders' equity)
|
-
|
5.68%
|
7.11%
|
3.76%
|
4.69%
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
9.000
|
9.590
|
9.220
|
9.050
|
8.820
|
Cash Flow per Share
2 |
-
|
0.4200
|
0.7600
|
0.8200
|
1.010
|
1.120
|
Capex
1 |
-
|
14.6
|
23.9
|
26.5
|
26.7
|
28
|
Capex / Sales
|
-
|
1.42%
|
1.91%
|
1.86%
|
1.71%
|
1.62%
|
Announcement Date
|
4/30/21
|
3/25/22
|
3/23/23
|
3/22/24
|
-
|
-
|
Last Close Price
6.54
CAD Average target price
10.05
CAD Spread / Average Target +53.74% Consensus |
1st Jan change
|
Capi.
|
---|
| -6.03% | 901M | | -14.92% | 84.68B | | +13.30% | 81.12B | | +10.92% | 29.4B | | -12.71% | 16.73B | | -3.06% | 16.36B | | -2.63% | 14.92B | | -31.75% | 11.77B | | -1.42% | 11.72B | | +27.44% | 11.71B |
Other Healthcare Facilities & Services
|